Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07178210 · ClinicalTrials.gov registry record · NA
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
A NA study of Alzheimer Disease and Lymphatic Obstruction, sponsored by MMI (Medical Microinstruments, Inc.).
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07178210 is a NA study of Alzheimer Disease and Lymphatic Obstruction that is actively recruiting participants, run by MMI (Medical Microinstruments, Inc.). The registered enrollment target is 15 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07178210, a NA study of Alzheimer Disease and Lymphatic Obstruction, is actively recruiting participants, sponsored by MMI (Medical Microinstruments, Inc.).
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.
Conditions Studied
Interventions
- DEVICE Symani Surgical System
Study Locations (1)
Florida
- Baptist Health Research Institute - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-03-31 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07178210
The ClinicalTrials.gov registry entry for NCT07178210 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is MMI (Medical Microinstruments, Inc.), which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Symani Surgical System is the first listed.
NCT07178210 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07178210 about?
NCT07178210 is a clinical study titled "Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease". The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.
What is the current status of trial NCT07178210?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-03-31. Estimated completion is 2027-08-31.
What conditions does trial NCT07178210 study?
This clinical trial studies the following conditions: Alzheimer Disease, Lymphatic Obstruction.
What interventions are being tested in trial NCT07178210?
The interventions under investigation include: Symani Surgical System (DEVICE).
Who is sponsoring clinical trial NCT07178210?
This trial is sponsored by MMI (Medical Microinstruments, Inc.), which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07178210 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.